What is Deborah Stewart’s total AVAH share ownership after these awards?

After the reported transactions, Deborah Stewart beneficially owned 331,622 shares of Aveanna common stock directly. This total includes 847 shares previously acquired under Aveanna Healthcare’s Employee Stock Purchase Plan and reflects the additional vested and granted equity reported on February 14, 2026.

AVAH Form 4 reports acquisition/exercise transactions

Stewart Deborah reported acquisition or exercise transactions in a Form 4 filing for AVAH.

Accepted by SEC EDGAR 02/17/2026 - 05:30 PM EST

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

Stewart Deborah reported acquisition or exercise transactions in a Form 4 filing for AVAH. The filing lists transactions totaling 79,099 shares. Following the reported transactions, holdings were 331,622 shares.

Insider Trade Summary

Grant/Award: 79,099 shares

Grant/Award 3 txns

Insider Stewart Deborah

Role SVP, Chief Accounting Officer

Type	Security	Shares	Price	Value
Grant/Award	Common Stock, par value $0.01 per share	11,663	$0.00	$0.00
Grant/Award	Common Stock, par value $0.01 per share	39,062	$0.00	$0.00
Grant/Award	Common Stock, par value $0.01 per share	28,374	$0.00	$0.00

Holdings After Transaction: Common Stock, par value $0.01 per share — 331,622 shares (Direct)

Footnotes (4)

F1. Represents shares earned upon vesting of performance-based restricted stock units issued pursuant to the Company's 2022 long-term incentive awards.
F2. Represents shares earned upon vesting of performance-based restricted stock units issued pursuant to the Company's 2023 long-term incentive awards.
F3. Grant of stock-settled restricted stock unit, subject to three-year cliff vesting.
F4. Includes 847 shares acquired under the Registrant's Employee Stock Purchase Plan (the "ESPP") in December 2025

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did AVAH executive Deborah Stewart report?

Deborah Stewart reported acquiring Aveanna common stock through equity awards, not open-market purchases. She received vested performance-based restricted stock units from 2022 and 2023 incentive awards and a new stock-settled restricted stock unit grant, all at a stated price of $0 per share as compensation.

How many AVAH shares did Deborah Stewart acquire in the latest Form 4?

Deborah Stewart acquired 11,663 shares from 2022 performance units, 39,062 shares from 2023 performance units, and 28,374 stock-settled restricted stock units. All were awarded on February 14, 2026 as part of Aveanna Healthcare’s long-term incentive and restricted stock unit compensation programs.

Were the AVAH shares in this Form 4 purchased in the market?

No, the Aveanna shares were not market purchases. They were acquired at a price of $0 per share through vesting of performance-based restricted stock units from 2022 and 2023 awards, plus a new grant of stock-settled restricted stock units under company compensation plans.

What are the vesting terms of Deborah Stewart’s new AVAH restricted stock units?

The new Aveanna grant to Deborah Stewart consists of stock-settled restricted stock units totaling 28,374 shares. These units are subject to three-year cliff vesting, meaning the entire award vests at once after three years, assuming the applicable service or other conditions are satisfied.

Which Aveanna incentive plans are referenced in Deborah Stewart’s Form 4?

The filing references Aveanna Healthcare’s 2022 and 2023 long-term incentive awards, which granted performance-based restricted stock units that have now vested into shares, and the company’s Employee Stock Purchase Plan, under which she had previously acquired 847 shares included in her beneficial ownership total.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Stewart Deborah

(Last)

(First)

(Middle)

C/O AVEANNA HEALTHCARE HOLDINGS INC.

400 INTERSTATE NORTH PARKWAY SE

(Street)

ATLANTA

30339

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
Aveanna Healthcare Holdings, Inc. [ AVAH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	SVP, Chief Accounting Officer

3. Date of Earliest Transaction (Month/Day/Year)
02/14/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock, par value $0.01 per share	02/14/2026		A		11,663⁽¹⁾	A	$0	264,186⁽⁴⁾	D
Common Stock, par value $0.01 per share	02/14/2026		A		39,062⁽²⁾	A	$0	303,248	D
Common Stock, par value $0.01 per share	02/14/2026		A		28,374⁽³⁾	A	$0	331,622	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. Represents shares earned upon vesting of performance-based restricted stock units issued pursuant to the Company's 2022 long-term incentive awards.

2. Represents shares earned upon vesting of performance-based restricted stock units issued pursuant to the Company's 2023 long-term incentive awards.

3. Grant of stock-settled restricted stock unit, subject to three-year cliff vesting.

4. Includes 847 shares acquired under the Registrant's Employee Stock Purchase Plan (the "ESPP") in December 2025

	/s/ Jonathan Beckler, Attorney-in-Fact	02/17/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR